Eric Lang - 15 Feb 2024 Form 3 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Chief Medical Officer
Signature
/s/ Eric Daniel Lang
Issuer symbol
CHRO
Transactions as of
15 Feb 2024
Net transactions value
$0
Form type
3
Filing time
15 Feb 2024, 20:12:17 UTC
Next filing
18 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CHRO Stock Options 15 Feb 2024 Common Stock 24,223 $22.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 15, 2023, the Reporting Person was granted stock options to purchase 24,223 shares of common stock at an exercise price of $22.68 per share. 1,864 shares of such options became exercisable on August 15, 2023, 1,864 shares of such options became exercisable on November 15, 2023, 1,864 shares of such options will become exercisable on February 15, 2024 and the remaining 18,631 shares of such options shall become exercisable in equal installments on a quarterly basis, subject to the Reporting Person's continued service to Issuer.

Remarks:

Exhibit 24 - Power of Attorney